| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 147 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 110 |
| 2 | TACROLIMUS OINTMENT 0.1% | 110 |
| 3 | MYCOPHENOLATE MOFETIL | 98 |
| 4 | PACLITAXEL | 69 |
| 5 | PREDNISONE | 68 |
| 6 | GEMCITABINE HYDROCHLORIDE | 67 |
| 7 | BEVACIZUMAB | 58 |
| 8 | ADALIMUMAB | 57 |
| 9 | CYCLOSPORINE | 55 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLOXURIDINE | 2 | 0.0116 |
| 1 | ESTRONE | 1 | 0.0093 |
| 2 | ETHIODIZED OIL | 10 | 0.0077 |
| 3 | ALUMINUM CHLORIDE | 1 | 0.0066 |
| 4 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 5 | AZATHIOPRINE SODIUM | 12 | 0.0047 |
| 6 | NISOLDIPINE | 5 | 0.0042 |
| 7 | COLLOIDAL OATMEAL | 1 | 0.0039 |
| 8 | REPOTRECTINIB | 1 | 0.0036 |
| 9 | SELADELPAR LYSINE | 1 | 0.0036 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 1 | Bile Acid [EPC] | 43 | 0.0019 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 32 | 0.0015 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 5 | Provitamin D2 Compound [EPC] | 31 | 0.0010 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 88 | 0.0009 |
| 7 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 34 | 0.0007 |
| 9 | Antihypoglycemic Agent [EPC] | 3 | 0.0007 |